During the COVID-19 pandemic, we saw the remarkable power of genomics in helping us keep track of new viral variants. Several scientists argue that Africa should continue to invest in genomics to support disease control and public health. Sue Segar asks what this means in practice and why it is considered so critically important.
Tuberculosis (TB) can be resistant to treatment with several different drugs. Tests that identify which drugs someone’s TB is resistant to are critical to ensuring that people are not treated with drugs that don’t work for them, especially given the significant side effects associated with some of the drugs. Elri Voigt assesses the state of play in testing for TB drug resistance and the promise of exciting new technologies, such as whole genome sequencing.
South African bioinformatics expert Professor Tulio de Oliveira was recently honoured with Time Magazine’s 100 most influential people award. Biénne Huisman sat down with him to talk about his part in the discovery of new COVID-19 variants, his chats with the President, and the treasure trove of scientific research excellence in Africa.
